SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001395064-19-000040
Filing Date
2019-11-06
Accepted
2019-11-06 06:08:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D sc13d_110619.htm SC 13D 111537
  Complete submission text file 0001395064-19-000040.txt   113062
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089
Business Address 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089 650-325-5156
Phathom Pharmaceuticals, Inc. (Subject) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91182 | Film No.: 191194962
SIC: 2834 Pharmaceutical Preparations